Nath Bio-Genes, a company in the Other Agricultural Products industry, reported revenue of ₹328 crore and net profit of ₹32 crore for the June 2026 quarter.
Nath Bio-Genes (NSE: NATHBIOGEN) closed at ₹132.73 on 20 Nov 2026, down 17.7% over the past year. Its market capitalisation is ₹252 crore and it trades at 7.5 times earnings.
Incorporated in 1993, Nath Bio-Genes Ltd is in the business of Production, Processing, and Marketing of Hybrid and GM Seeds
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.